2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) - Buse, John B.; Wexler, Deborah J.; Tsapas, Apostolos; Rossing, Peter; Mingrone, Geltrude; Mathieu, Chantal; D’Alessio, David A.; Davies, Melanie J. (Diabetes care, 2020)
Keywords: Agonists; Albumins; Cardiovascular diseases; Cardiovascular Diseases - blood; Cardiovascular Diseases - prevention & control; Clinical trials; Consensus; Consensus Report Update; Creatinine; Death; Diabetes; Diabetes Complications - blood; Diabetes Complications - drug therapy; Diabetes Complications - prevention & control; Diabetes mellitus; Diabetes mellitus (non-insulin dependent); Diabetes Mellitus, Type 2 - blood; Diabetes Mellitus, Type 2 - complications; Diabetes Mellitus, Type 2 - therapy; Ejection fraction; Europe; Glomerular filtration rate; GLP-1 receptor agonists; Glucagon; Glucagon-like peptide 1; Health risk assessment; Heart diseases; Heart failure; History, 21st Century; Humans; Hyperglycemia; Hyperglycemia - blood; Hyperglycemia - etiology; Hyperglycemia - therapy; Hypoglycemic Agents - classification; Hypoglycemic Agents - therapeutic use; Kidney diseases; Male; Mortality; Renal Insufficiency, Chronic - blood; Renal Insufficiency, Chronic - drug therapy; Societies, Medical - organization & administration; Societies, Medical - standards; Sodium-glucose cotransporter; Sodium-Glucose Transporter 2 Inhibitors - therapeutic use; United States; United States; Europe